Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in APUS — Apimeds Pharmaceuticals US, Inc.

CIK 1214717 BOSTON, MA
Back to APUS Full portfolio

Position in APUS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$31,602
-$40,048 QoQ
Shares Held
3,511
-12.3% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 7 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APUS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. APUS ranks #61 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 13,289,622 $954,992,236
2 UTHR
UNITED THERAPEUTICS Corp
 996,598 $539,986,694
3 VTRS
Viatris Inc
 32,807,906 $520,989,547
4 TEVA
Teva Pharmaceutical Industries Ltd
 11,607,196 $393,251,799
5 NBIX
Neurocrine Biosciences Inc
 2,138,777 $360,469,474
6 ELAN
Elanco Animal Health Inc
 11,302,057 $278,143,622
7 ALKS
Alkermes plc.
 4,477,876 $234,640,702
8 LNTH
Lantheus Holdings, Inc.
 1,841,367 $204,281,254

All Filings in APUS

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,602 35,114
2026-03-31 $71,650 40,051
2025-12-31 — 34,888
2025-09-30 — 30,754